Patients should understand: the importance of maintaining hydration despite reduced appetite, which symptoms warrant medical contact, how to use oral rehydration solutions if needed, and the value of keeping scheduled follow-up appointments
GLP-1 therapies reduced inflammatory markers and protected kidney function in animals and humans, including in the FLOW trial
Administration is typically via subcutaneous injection in the abdomen, thigh, or upper arm
Going forward, special attention should be paid to the exploration of potential unwanted effects, particularly those affecting cardiovascular health with heart rate being one of the easiest variables to monitor
(7) LT stress-bearing tendency depends on a favorable kind of interaction between stomatal conductance, photosynthetic rate and transpiration rate as seen under G2C treatment
The oral formulation is in Phase II development and the subcutaneous formulation is planned for Phase III testing in 2025